ResMed myAir is an easy-to-use online support program and app, exclusively available for users of AirSense™ and AirCurve™ devices with built-in cellular technology.* By allowing patients to track their nightly sleep data and through interactive coaching, myAir empowers patients to stay engaged with their therapy – an important part of helping them stay adherent long-term. And with patients more involved in managing their own therapy, myAir may help reduce callbacks and allow you to manage your sleep patients more efficiently.
Users of AirSense 11 will have access to enhanced myAir features like Personal Therapy Assistant and Care Check-In, which guide patients through setup, check in on their progress and provide tailored support content to help them self-resolve common therapy challenges.1
* Cellular connectivity is available only on specific device models. Cellular connectivity depends on network availability.
Patients can download the myAir app for their Apple® iPhone® on the App Store® or for their compatible Android™ smartphone on the Google Play™ store. Alternatively, they can register online at myAir.ResMed.com.
The dashboard section of myAir is where your patients can find sleep data from the previous day with intuitive icons and charts that make tracking therapy simple and fun. Patients receive a myAir score each night based on a combination of four sleep factors: usage hours, mask seal, events per/hour and mask on/off events.
myAir helps new patients develop good habits for therapy compliance success by motivating them to work towards a nightly usage goal. Goal tracking automatically tracks their progress on their dashboard and awards patients with achievement badges along the way. The goal is to use therapy at least four hours per night for 21 nights in a 30-day period.
Patients who used the myAir app with goal tracking experienced a 2.09% improvement in compliance compared to patients who used the myAir app without goal tracking.2
Delivered via email or push notifications, myAir will send three different types of messages to patients:
myAir's sleep library is a tailored collection of how-to instructions, videos and other support materials to help your patients on their sleep apnea therapy journey. It also includes personalised information based on their device model and mask type/model.
myAir and AirView™ ̶ when used together have been shown to increase patients’ 90-day therapy compliance to 87%, compared to 70% of patients monitored in AirView alone3** Furthermore, patients using myAir also consistently on average slept one hour longer each night.3
myAir can send monthly cleaning and inspection reminders to help educate patients on the benefits of maintaining their therapy equipment and to let them know just when and how they should do so.
These reminders:
Encourage your patients to get started today!
A cloud-based patient management system that brings you data on demand.
A standard fixed-pressure therapy device with AutoRamp™. Features built-in wireless connectivity.*
An advanced fixed-pressure therapy device with Climate Control, AutoRamp™ and advanced CSA and CSR detection. Features built-in wireless connectivity.*
A premium auto-adjusting therapy device with Climate Control, AutoRamp™, and advanced CSA and CSR detection. Also features built-in wireless connectivity.*
A premium auto-adjusting therapy device featuring the first dedicated algorithm to respond to female-specific characteristics of OSA. Also features built-in wireless connectivity.*
Some features of ResMed myAir are only available in the myAir app and are specific to AirSense 11 users.
Internal ResMed a/b beta test of new patients using a ResMed AirSense 10 or AirSense 11 device and the myAir app. Compliance is defined as per the US CMS guidelines: PAP use for ≥ 4 h per night on at least 70% of nights during a consecutive 30-day period during the first 90 days of initial usage. Test conducted between May 24 - September 5, 2023. n =12,600 (Control = 6,300).
Malhotra et al. “Patient engagement using new technology to improve adherence to positive airway pressure therapy: A retrospective analysis,” CHEST, 2018; 153(4):843-850.
Android and Google Play are trademarks of Google, Inc., registered in the U.S. and other countries. Apple, App Store and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries.
* Cellular connectivity is available only on specific device models. Cellular connectivity depends on network availability.
** As defined by CMS criteria within the first 3 months of initial PAP therapy use: > 4 h/n, at least 70% of nights, during a consecutive 30-day period.